Edges in Network
| Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CEBPA |
| Upstream (Parents) |
|---|
| (<<) VTN → CEBPA |
| (<<) HLF → CEBPA |
| (<<) NR1I3 → CEBPA |
| (<<) SALL1 → CEBPA |
| (<<) AR → CEBPA |
| (<<) MAFF → CEBPA |
| (<<) SOX9 → CEBPA |
| Downstream (Children) |
|---|
| CEBPA → ONECUT1 (>>) |
| CEBPA → NEUROD1 (>>) |
| CEBPA → HOXA1 (>>) |
| CEBPA → TRIM29 (>>) |
| CEBPA → HOXB9 (>>) |
| CEBPA → SIX2 (>>) |
| CEBPA → MYT1 (>>) |
| CEBPA → HOXA7 (>>) |
| CEBPA → TFAP2A (>>) |
| CEBPA → IRX5 (>>) |
| CEBPA → MZF1 (>>) |
| CEBPA → NRL (>>) |
| CEBPA → MLL (>>) |
| CEBPA → FOSL2 (>>) |
| CEBPA → NKX2-8 (>>) |
| CEBPA → NR1I2 (>>) |
| CEBPA → NR3C2 (>>) |
| CEBPA → NR4A2 (>>) |
| CEBPA → NFAT5 (>>) |
| CEBPA → RB1 (>>) |
| CEBPA → SOX13 (>>) |
| CEBPA → CREB5 (>>) |
